文献速递消化道肿瘤与早癌食管胃疾病与幽门螺杆菌

DNA损伤信号作为胃肠上皮化生的抗癌屏障

DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia.
PubMed 文献 · Gut · 2020-01-14

本研究基于胃癌流行病学内镜监测项目的肠上皮化生活检样本,按突变负荷/体细胞拷贝数改变分为基因组稳定与不稳定两类,检测DNA损伤应答(DDR)标志γH2AX和增殖标志MCM2。结果显示基因组稳定肠上皮化生γH2AX水平较高,基因组不稳定者γH2AX较低且CD44v9升高、DNA修复基因启动子高甲基化。提示活跃DDR使癌前病变延迟进展。

要点

  • γH2AX水平与慢性炎症程度相关,基因组稳定肠上皮化生γH2AX较高。
  • 基因组不稳定肠上皮化生γH2AX较低、CD44v9升高、WRN/MLH1/RAD52启动子高甲基化。
  • 活跃DDR可能使肠上皮化生癌前状态潜伏期延长,延缓胃癌进展。

核心结论

  • 肠上皮化生中活跃的DNA损伤应答可能作为抗癌屏障,使病变在癌前状态经历更长潜伏期。
  • 基因组不稳定肠上皮化生γH2AX水平较低,提示DDR信号被克隆性绕过或失活后促进进展。

研究设计与样本

  • 样本来自胃癌流行病学内镜监测项目的肠上皮化生活检,已进行(表观)基因组特征分析。
  • 根据突变负荷/体细胞拷贝数改变(CNA)将肠上皮化生样本分为基因组稳定与不稳定两类。
  • 采用γH2AX和MCM2分别检测DDR信号和细胞增殖,并评估胃干细胞标志CD44v9表达。
  • 纳入代表胃癌进展谱系的组织芯片。

主要发现

  • MCM2阳性率在胃癌进展过程中增加。
  • γH2AX阳性从正常到胃炎和肠上皮化生阶段呈适度增加,胃癌阶段进一步增加。
  • γH2AX水平与慢性炎症程度相关。
  • 基因组稳定肠上皮化生病灶γH2AX水平较高,提示DDR信号具有保护性抗癌作用。
  • 基因组不稳定肠上皮化生病灶突变负荷/CNA较高,γH2AX水平较低,CD44v9表达升高,DNA修复基因WRN、MLH1和RAD52启动子呈适度高甲基化。

临床怎么用

  • 肠上皮化生活检中评估γH2AX等DDR标志可能有助于识别进展风险较低的基因组稳定病变。
  • CD44v9高表达合并γH2AX低水平或DNA修复基因高甲基化提示基因组不稳定肠上皮化生,需更密切监测。

局限性

  • 原文未明确报告样本量及统计显著性阈值。
  • 结论基于观察性活检样本,DDR信号与肠上皮化生进展的因果关系需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Intestinal metaplasia (IM) is a premalignant stage that poses a greater risk for subsequent gastric cancer (GC). However, factors regulating IM to GC progression remain unclear. Previously, activated DNA damage response (DDR) signalling factors were shown to engage tumour-suppressive networks in premalignant lesions. Here, we interrogate the relationship of DDR signalling to mutational accumulation in IM lesions. DESIGN: IM biopsies were procured from the gastric cancer epidemiology programme, an endoscopic surveillance programme where biopsies have been subjected to (epi)genomic characterisation. IM samples were classified as genome-stable or genome-unstable based on their mutational burden/somatic copy-number alteration (CNA) profiles. Samples were probed for DDR signalling and cell proliferation, using the markers γH2AX and MCM2, respectively. The expression of the gastric stem cell marker, CD44v9, was also assessed. Tissue microarrays representing the GC progression spectrum were included. RESULTS: MCM2-positivity increased during GC progression, while γH2AX-positivity showed modest increase from normal to gastritis and IM stages, with further increase in GC. γH2AX levels correlated with the extent of chronic inflammation. Interestingly, genome-stable IM lesions had higher γH2AX levels underscoring a protective anti-cancer role for DDR signalling. In contrast, genome-unstable IM lesions with higher mutational burden/CNAs had lower γH2AX levels, elevated CD44v9 expression and modest promoter hypermethylation of DNA repair genes WRN, MLH1 and RAD52. CONCLUSIONS: Our data suggest that IM lesions with active DDR will likely experience a longer latency at the premalignant state until additional hits that override DDR signalling clonally expand and promote progression. These observations provide insights on the factors governing IM progression.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Krishnan V, Lim DXE, Hoang PM, et al. DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia. Gut. 2020. PMID: 31937549. doi:10.1136/gutjnl-2019-319002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。